Taysha Gene Therapies Announces Queen’s University’s Receipt of Clinical Trial Application …,

TSHA-101 to be first bicistronic vector evaluated in human clinical trials; … Chief Medical Officer and Head of Research and Development of Taysha., TSHA-101 to be first bicistronic vector evaluated in human clinical trials; … Chief Medical Officer and Head of Research and Development of Taysha., Read More

Scroll to Top